Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1
|
作者：
Rieske, Piotr [1 ,2 ]
机构：
[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
[2] Celther Polska, Lodz, Poland
来源：
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期
关键词：
SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;
D O I：
10.5114/pja.2020.97913
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 50 条
  • [1] Analysis of SARS-CoV-2 vaccine against COVID-19
    Kazuyori, Taisuke
    Sato, Akihito
    Morimoto, Yasuhiro
    Ito, Akihiko
    Kuwano, Kazuyoshi
    RESPIROLOGY, 2023, 28 : 202 - 203
  • [2] Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
    Behera, Priyamadhaba
    Singh, Arvind Kumar
    Subba, Sonu Hangma
    Arjun, Mc
    Sahu, Dinesh Prasad
    Chandanshive, Pradnya Dilip
    Pradhan, Somen Kumar
    Parida, Swayam Pragyan
    Mishra, Abhisek
    Patro, Binod Kumar
    Batmanabane, Gitanjali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [3] Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease Running title: Propolis against SARS-CoV-2 infection and COVID-19
    Berretta, Andresa Aparecida
    Duarte Silveira, Marcelo Augusto
    Capcha, Jose Manuel Condor
    De Jong, David
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [4] COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
    Stojan Peric
    Milos Rankovic
    Ivo Bozovic
    Vanja Radosavljevic
    Ivan Marjanovic
    Ivana Basta
    Dragana Lavrnic
    Acta Neurologica Belgica, 2023, 123 : 529 - 536
  • [5] Correlates of protection against SARS-CoV-2 infection and COVID-19 disease
    Goldblatt, David
    Alter, Galit
    Crotty, Shane
    Plotkin, Stanley A.
    IMMUNOLOGICAL REVIEWS, 2022, 310 (01) : 6 - 26
  • [6] COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
    Peric, Stojan
    Rankovic, Milos
    Bozovic, Ivo
    Radosavljevic, Vanja
    Marjanovic, Ivan
    Basta, Ivana
    Lavrnic, Dragana
    ACTA NEUROLOGICA BELGICA, 2023, 123 (02) : 529 - 536
  • [7] Candidate drugs against SARS-CoV-2 and COVID-19
    McKee, Dwight L.
    Sternberg, Ariane
    Stange, Ulrike
    Laufer, Stefan
    Naujokat, Cord
    PHARMACOLOGICAL RESEARCH, 2020, 157
  • [8] Suggesting Ritonavir against COVID-19/SARS-CoV-2
    Choudhury, Shuvasish
    Mazumder, Muhammed Khairujjaman
    MEDICAL HYPOTHESES, 2020, 140
  • [9] The global battle against SARS-CoV-2 and COVID-19
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (10): : 1676 - U96
  • [10] Protection against SARS-CoV-2 after COVID-19 vaccination and previous infection
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (04): : 211 - 211
12345